JOANNE BLAIR-RANDOLPH: Open Payments
NPI 1144351123 · LYNWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,689 in 113 payments from 9 companies in 2025. Trend: 2023 $1,873 · 2024 $2,356 · 2025 $2,689
Food & beverage: $2,677Education: $12
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 26 | $618 |
| Janssen Pharmaceuticals, Inc | 18 | $509 |
| E.R. Squibb & Sons, L.L.C. | 14 | $461 |
| Neurocrine BioSciences, Inc. | 10 | $315 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $236 |
| Teva Pharmaceuticals USA, Inc. | 12 | $234 |
| Alkermes, Inc. | 11 | $210 |
| ABBVIE INC. | 3 | $66 |
| Axsome Therapeutics, Inc. | 2 | $41 |
Products named: INVEGA SUSTENNA, COBENFY, ABILIFY ASIMTUFII, INGREZZA, CAPLYTA, ARISTADA, UZEDY, ABILIFY MAINTENA.
Industry payments across CA — which companies pay providers there.
